Should screening programs for carbapenemase-producing strains be implemented in ICU patients?

Enferm Infecc Microbiol Clin. 2017 Jun-Jul;35(6):331-332. doi: 10.1016/j.eimc.2016.12.002. Epub 2017 Jan 16.
[Article in English, Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Bacterial Proteins / biosynthesis*
  • Cross Infection / drug therapy
  • Cross Infection / prevention & control*
  • Diagnostic Screening Programs* / organization & administration
  • Drug Resistance, Bacterial
  • Enterobacteriaceae / enzymology*
  • Enterobacteriaceae / isolation & purification
  • Enterobacteriaceae Infections / drug therapy
  • Enterobacteriaceae Infections / prevention & control*
  • Humans
  • Intensive Care Units*
  • beta-Lactamases / biosynthesis*

Substances

  • Bacterial Proteins
  • beta-Lactamases
  • carbapenemase